QYResearch Reviewed: In 2016, Global Revenue of Bacillus Coagulans is nearly 16.8 M USD

Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary. Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey's Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus; its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Berge’s, it was finally transferred to the genus Bacillus. DNA-based technology was used in distinguishing between the two genera of bacteria which are morphologically similar and possess similar physiological and biochemical characteristics.

According to QYResearch, In the last several years, Global market of Bacillus Coagulans developed rapidly, with an average growth rate of 9%. In 2016, Global Revenue of Bacillus Coagulans is nearly 16.8 M USD; the actual sales are about 26 MT. The global average price of Bacillus Coagulans is in the increasing trend, from 620 USD/Kg in 2012 to 650 USD/Kg in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.

The classification of Bacillus Coagulans includes Below 100 B, 100-200 B and Above 200 B. This refers to the effective amount of viable bacteria, and B means Billion CFU/g. The proportion of 100-200 B in 2016 is about 47%.

Bacillus Coagulans is widely used in Drugs, Food, Beverage and Supplement Products. The most proportion of Bacillus Coagulans is Supplement Products, and the proportion in 2016 is 37.5%. The trend of Supplement Products is increasing.

North America is the largest consumption place, with a consumption market share nearly 38% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.

Market competition is not intense. Ganeden, Sabinsa, Mitsubishi, Nebraska Cultures, Synbiotech, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. 

More Info: http://www.qyresearchglobal.com/goods-1359399.html

This article was first released by QYResearch, if reproduced, please indicate the source.

Marketing: sales@qyresearch.com

Media Contact: press@qyresearch.com